デフォルト表紙
市場調査レポート
商品コード
1425287

生物製剤受託開発の世界市場レポート 2024年

Biologics Contract Development Global Market Report 2024

出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 200 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.49円
生物製剤受託開発の世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2~10営業日
ご注意事項 :
本レポートの納品は、最新情報反映のため受注時に適宜更新しお届けいたします。
更新情報の反映作業にあたり納期もレポート毎に異なりますので、ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

生物製剤受託開発の市場規模は、近年急速に拡大しています。2023年の69億4,000万米ドルから、2024年には77億米ドルへ、CAGR11.0%で成長すると予測されています。過去実績期間に観察された成長は、様々な要因に起因しています。まず、この期間に拡大を経験した生物製剤市場全体の成長に関連しています。製薬業界における生物学的製剤の開発と利用を特徴とするバイオ医薬品の台頭が重要な役割を果たしました。生物学的製剤は開発と製造の両面で複雑な性質を持つため、専門的な開発受託サービスへの需要が高まりました。この業界における特許の失効も、企業が費用効率の高いアウトソーシングの選択肢を模索する原動力となり、生物製剤の開発受託サービスへの依存を高めることにつながりました。

戦略的買収は、生物製剤受託開発市場における企業の地位を強化する上で極めて重要な役割を果たしています。2022年2月、 RecipharmはVibalogicsとArranta Bioを買収し、先端治療薬におけるプレゼンスを強化し、米国におけるウイルス療法製造能力を拡大しました。VibalogicsとArranta Bioは共に開発・製造受託企業であり、生物製剤受託開発分野におけるRecipharmの戦略的成長に寄与する極めて重要な買収でした。

北米は2023年の生物製剤受託開発市場シェアで最大の地域です。アジア太平洋は予測期間中に最も急成長する地域となる見込みです。生物製剤受託開発市場レポートの対象地域は、アジア太平洋、西欧、東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の生物製剤受託開発市場の促進要因と抑制要因
    • 市場の促進要因
    • 市場の抑制要因
  • 世界の生物製剤受託開発市場規模実績と成長、2018年~2023年
  • 世界の生物製剤受託開発市場規模と成長予測、2023年~2028年、2033年

第6章 市場セグメンテーション

  • 世界の生物製剤受託開発市場、由来別セグメンテーション、実績と予測、2018年~2023年、2023年~2028年、2033年
  • 微生物
  • 哺乳類
  • その他の由来
  • 世界の生物製剤受託開発市場、適応症別セグメンテーション、実績と予測、2018年~2023年、2023年~2028年、2033年
  • 腫瘍学
  • 免疫疾患
  • 心血管障害
  • 血液疾患
  • その他の適応症
  • 世界の生物製剤受託開発市場、製品サービス別セグメンテーション、実績と予測、2018年~2023年、2023年~2028年、2033年
  • 細胞株の開発
  • プロセス開発
  • その他製品サービス

第7章 地域と国の分析

  • 世界の生物製剤受託開発市場、地域別、実績と予測、2018年~2023年、2023年~2028年、2033年
  • 世界の生物製剤受託開発市場、国別、実績と予測、2018年~2023年、2023年~2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 生物製剤受託開発市場の競合情勢
  • 生物製剤受託開発市場企業プロファイル
    • WuXi Biologics
    • Abzena Ltd.
    • Fujifilm Diosynth Biotechnologies
    • BI Biopharma
    • AGC Biologics

第31章 競合ベンチマーキング

第32章 競合ダッシュボード

第33章 主要な合併と買収

第34章 将来の見通しと可能性の分析

第35章 付録

目次
Product Code: r12518

Biologics Contract Development Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on biologics contract development market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for biologics contract development? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The biologics contract development market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Source: Microbial; Mammalian; Others Sources
  • 2) By Indication: Oncology; Immunological disorders; Cardiovascular disorders; Hematological disorders; Others Indications
  • 3) By Product Service: Cell Line Development; Process Development; Others Product Services
  • Companies Mentioned: WuXi Biologics; Abzena Ltd.; Fujifilm Diosynth Biotechnologies; KBI Biopharma; AGC Biologics
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Biologics contract development involves companies that offer development and manufacturing services for biologics on a contractual basis to pharmaceutical firms. This outsourcing approach allows pharmaceutical companies to concentrate on marketing, research and development (R&D), and brand-building activities while entrusting the manufacturing of biologics to external service providers.

The primary sources for biologics contract development include microbial, mammalian, and other sources. Microbial sources are utilized in the production of various biologics. Biologics contract development caters to various indications, including oncology, immunological disorders, cardiovascular disorders, hematological disorders, and others. The product services offered in biologics contract development encompass cell line development, process development, and other related services.

The biologics contract development market research report is one of a series of new reports from The Business Research Company that provides biologics contract development market statistics, including biologics contract development industry global market size, regional shares, competitors with a biologics contract development market share, detailed biologics contract development market segments, market trends and opportunities, and any further data you may need to thrive in the biologics contract development industry. This biologics contract development market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The biologics contract development market size has grown rapidly in recent years. It will grow from $6.94 billion in 2023 to $7.7 billion in 2024 at a compound annual growth rate (CAGR) of 11.0%. The growth observed in the historical period can be attributed to various factors. Firstly, it is linked to the overall growth of the biologics market, which experienced expansion during this period. The rise in biopharmaceuticals, characterized by the development and utilization of biological products in the pharmaceutical industry, played a significant role. The inherent complexity of biologics, both in terms of development and manufacturing, contributed to the demand for specialized contract development services. Patent expirations in the industry also drove companies to explore cost-efficient outsourcing options, leading to increased reliance on biologics contract development services.

The biologics contract development market size is expected to see rapid growth in the next few years. It will grow to $11.68 billion in 2028 at a compound annual growth rate (CAGR) of 11.0%. Anticipated growth in the forecast period is driven by key factors such as the integration of digitalization and data analytics, effective risk management practices, the flexibility and scalability offered by contract development services, a substantial increase in research and development (R&D) investments, and the growing focus on precision medicine and personalized therapies. Major trends expected in this period include the prominence of regenerative medicine, a continued emphasis on robust risk mitigation strategies, a rise in global collaborations, the adoption of advanced technologies, and a significant focus on technological integration within the industry. These trends reflect the dynamic landscape of the contract development sector and the ongoing pursuit of innovative and efficient business practices.

The biologics contract development market is poised for growth due to the increasing prevalence of chronic diseases, necessitating ongoing medical attention and novel drug development. The World Health Organization reported in April 2021 that approximately 71% of global deaths, totaling 41 million people annually, are attributed to chronic diseases. This surge in chronic conditions fuels the demand for biologics, positioning the biologics contract development market for substantial expansion.

A significant upswing in investments in biopharmaceuticals is a key driver of the biologics contract development market. The heightened demand for biopharmaceuticals, encompassing monoclonal antibodies, recombinant proteins, and gene therapies, prompts companies to outsource development activities. In January 2021, FUJIFILM Corporation invested $2 billion to establish a large-scale cell culture production site in the United States, accelerating its biopharmaceutical contract development and manufacturing business. This influx of investment is set to play a pivotal role in propelling the biologics contract development market.

Technological advancements are reshaping the biologics contract development market, with major players incorporating advanced technologies to maintain their market standing. In January 2022, Lonza introduced the bYlok technology platform, designed to facilitate the design and manufacture of bispecific antibodies. This platform addresses challenges related to light-heavy chain mispairing, ensuring high yields, accuracy exceeding 95%, and compatibility with a monoclonal antibody (mAb)-like format. Technological innovation remains a focal point in sustaining competitiveness within the biologics contract development sector.

Major companies operating in the biologics contract development arena are integrating data analytics into their processes, fostering improved monitoring, analysis, and decision-making. This integration of digital technologies enhances efficiency and productivity in biologics development. In October 2022, Evotec SE launched PanHunter, part of the PanOmics data access and analytics technology, which enables advanced patient population stratification and prediction of efficacy and toxicity profiles. This incorporation of data analytics signifies a strategic move towards leveraging digital tools for enhanced insights in the biologics contract development market.

Strategic acquisitions play a pivotal role in reinforcing companies' positions in the biologics contract development market. In February 2022, Recipharm acquired Vibalogics and Arranta Bio, strengthening its presence in advanced therapy medicinal products and expanding virotherapy manufacturing capabilities in the US. Vibalogics and Arranta Bio, both contract development and manufacturing organizations, were pivotal acquisitions contributing to Recipharm's strategic growth in the biologics contract development sector.

Major companies operating in the biologics contract development market report are WuXi Biologics, Abzena Ltd., Fujifilm Diosynth Biotechnologies, KBI Biopharma, AGC Biologics, Thermo Fisher Scientific Inc., LakePharma Inc., GenScript Biotech Corporation, Bionova Scientific Inc., Boehringer Ingelheim GmbH, STC Biologics, Siegfried Evionnaz SA, BioAgilytix Labs Inc., Samsung BioLogics, Forge Biologics, Lonza Group, Catalent Inc., AbbVie Inc., Cytovance Biologics, Emergent BioSolutions, Eurofins CDMO, Meridian Life Science Inc., Merck Group, Patheon N.V., ProBioGen AG, Rentschler Biopharma SE, Sartorius AG, Syngene International Limited, Vibalogics GmbH, Yposkesi, and ZymoGenetics Inc.

North America was the largest region in the biologics contract development market share in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biologics contract development market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the biologics contract development market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The biologics contract development market includes revenues earned by entities by sourcing, solid and specialized formulation development, and process analytics development. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Biologics Contract Developmen Market Characteristics

3. Biologics Contract Developmen Market Trends And Strategies

4. Biologics Contract Developmen Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Biologics Contract Developmen Market Size and Growth

  • 5.1. Global Biologics Contract Developmen Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Biologics Contract Developmen Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Biologics Contract Developmen Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Biologics Contract Developmen Market Segmentation

  • 6.1. Global Biologics Contract Developmen Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Microbial
  • Mammalian
  • Others Soruces
  • 6.2. Global Biologics Contract Developmen Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Oncology
  • Immunological disorders
  • Cardiovascular disorders
  • Hematological disorders
  • Others Indications
  • 6.3. Global Biologics Contract Developmen Market, Segmentation By Product Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Cell Line Development
  • Process Development
  • Others Product Services

7. Biologics Contract Developmen Market Regional And Country Analysis

  • 7.1. Global Biologics Contract Developmen Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Biologics Contract Developmen Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Biologics Contract Developmen Market

  • 8.1. Asia-Pacific Biologics Contract Developmen Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Biologics Contract Developmen Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Biologics Contract Developmen Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Biologics Contract Developmen Market, Segmentation By Product Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Biologics Contract Developmen Market

  • 9.1. China Biologics Contract Developmen Market Overview
  • 9.2. China Biologics Contract Developmen Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Biologics Contract Developmen Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Biologics Contract Developmen Market, Segmentation By Product Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Biologics Contract Developmen Market

  • 10.1. India Biologics Contract Developmen Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Biologics Contract Developmen Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Biologics Contract Developmen Market, Segmentation By Product Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Biologics Contract Developmen Market

  • 11.1. Japan Biologics Contract Developmen Market Overview
  • 11.2. Japan Biologics Contract Developmen Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Biologics Contract Developmen Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Biologics Contract Developmen Market, Segmentation By Product Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Biologics Contract Developmen Market

  • 12.1. Australia Biologics Contract Developmen Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Biologics Contract Developmen Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Biologics Contract Developmen Market, Segmentation By Product Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Biologics Contract Developmen Market

  • 13.1. Indonesia Biologics Contract Developmen Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Biologics Contract Developmen Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Biologics Contract Developmen Market, Segmentation By Product Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Biologics Contract Developmen Market

  • 14.1. South Korea Biologics Contract Developmen Market Overview
  • 14.2. South Korea Biologics Contract Developmen Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Biologics Contract Developmen Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Biologics Contract Developmen Market, Segmentation By Product Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Biologics Contract Developmen Market

  • 15.1. Western Europe Biologics Contract Developmen Market Overview
  • 15.2. Western Europe Biologics Contract Developmen Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Biologics Contract Developmen Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Biologics Contract Developmen Market, Segmentation By Product Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Biologics Contract Developmen Market

  • 16.1. UK Biologics Contract Developmen Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Biologics Contract Developmen Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Biologics Contract Developmen Market, Segmentation By Product Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Biologics Contract Developmen Market

  • 17.1. Germany Biologics Contract Developmen Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Biologics Contract Developmen Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Biologics Contract Developmen Market, Segmentation By Product Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Biologics Contract Developmen Market

  • 18.1. France Biologics Contract Developmen Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Biologics Contract Developmen Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Biologics Contract Developmen Market, Segmentation By Product Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Biologics Contract Developmen Market

  • 19.1. Italy Biologics Contract Developmen Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Biologics Contract Developmen Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Biologics Contract Developmen Market, Segmentation By Product Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Biologics Contract Developmen Market

  • 20.1. Spain Biologics Contract Developmen Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Biologics Contract Developmen Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Biologics Contract Developmen Market, Segmentation By Product Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Biologics Contract Developmen Market

  • 21.1. Eastern Europe Biologics Contract Developmen Market Overview
  • 21.2. Eastern Europe Biologics Contract Developmen Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Biologics Contract Developmen Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Biologics Contract Developmen Market, Segmentation By Product Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Biologics Contract Developmen Market

  • 22.1. Russia Biologics Contract Developmen Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Biologics Contract Developmen Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Biologics Contract Developmen Market, Segmentation By Product Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Biologics Contract Developmen Market

  • 23.1. North America Biologics Contract Developmen Market Overview
  • 23.2. North America Biologics Contract Developmen Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Biologics Contract Developmen Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Biologics Contract Developmen Market, Segmentation By Product Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Biologics Contract Developmen Market

  • 24.1. USA Biologics Contract Developmen Market Overview
  • 24.2. USA Biologics Contract Developmen Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Biologics Contract Developmen Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Biologics Contract Developmen Market, Segmentation By Product Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Biologics Contract Developmen Market

  • 25.1. Canada Biologics Contract Developmen Market Overview
  • 25.2. Canada Biologics Contract Developmen Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Biologics Contract Developmen Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Biologics Contract Developmen Market, Segmentation By Product Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Biologics Contract Developmen Market

  • 26.1. South America Biologics Contract Developmen Market Overview
  • 26.2. South America Biologics Contract Developmen Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Biologics Contract Developmen Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Biologics Contract Developmen Market, Segmentation By Product Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Biologics Contract Developmen Market

  • 27.1. Brazil Biologics Contract Developmen Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Biologics Contract Developmen Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Biologics Contract Developmen Market, Segmentation By Product Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Biologics Contract Developmen Market

  • 28.1. Middle East Biologics Contract Developmen Market Overview
  • 28.2. Middle East Biologics Contract Developmen Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Biologics Contract Developmen Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Biologics Contract Developmen Market, Segmentation By Product Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Biologics Contract Developmen Market

  • 29.1. Africa Biologics Contract Developmen Market Overview
  • 29.2. Africa Biologics Contract Developmen Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Biologics Contract Developmen Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Biologics Contract Developmen Market, Segmentation By Product Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Biologics Contract Developmen Market Competitive Landscape And Company Profiles

  • 30.1. Biologics Contract Developmen Market Competitive Landscape
  • 30.2. Biologics Contract Developmen Market Company Profiles
    • 30.2.1. WuXi Biologics
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Abzena Ltd.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Fujifilm Diosynth Biotechnologies
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. BI Biopharma
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. AGC Biologics
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Global Biologics Contract Developmen Market Competitive Benchmarking

32. Global Biologics Contract Developmen Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Biologics Contract Developmen Market

34. Biologics Contract Developmen Market Future Outlook and Potential Analysis

  • 34.1 Biologics Contract Developmen Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Biologics Contract Developmen Market In 2028 - Segments Offering Most New Opportunities
  • 34.3 Biologics Contract Developmen Market In 2028 - Growth Strategies
    • 34.3.1 Market Trend Based Strategies
    • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35.4. Research Inquiries
  • 35.5. The Business Research Company
  • 35.6. Copyright And Disclaimer